全文获取类型
收费全文 | 3050篇 |
免费 | 2篇 |
专业分类
综合类 | 3篇 |
化学工业 | 12篇 |
建筑科学 | 8篇 |
轻工业 | 1篇 |
水利工程 | 1篇 |
石油天然气 | 2篇 |
无线电 | 1篇 |
一般工业技术 | 4篇 |
冶金工业 | 3013篇 |
自动化技术 | 7篇 |
出版年
2024年 | 1篇 |
2021年 | 2篇 |
2014年 | 2篇 |
2013年 | 1篇 |
2012年 | 5篇 |
2011年 | 1篇 |
2010年 | 1篇 |
2008年 | 1篇 |
2006年 | 5篇 |
2005年 | 3篇 |
2004年 | 2篇 |
2003年 | 5篇 |
2002年 | 1篇 |
2001年 | 1篇 |
1999年 | 89篇 |
1998年 | 893篇 |
1997年 | 496篇 |
1996年 | 315篇 |
1995年 | 171篇 |
1994年 | 149篇 |
1993年 | 173篇 |
1992年 | 25篇 |
1991年 | 35篇 |
1990年 | 38篇 |
1989年 | 45篇 |
1988年 | 53篇 |
1987年 | 54篇 |
1986年 | 35篇 |
1985年 | 33篇 |
1983年 | 11篇 |
1982年 | 14篇 |
1981年 | 20篇 |
1980年 | 38篇 |
1979年 | 4篇 |
1978年 | 12篇 |
1977年 | 94篇 |
1976年 | 216篇 |
1975年 | 6篇 |
1973年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有3052条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
7.
C Bokemeyer O K?hrmann J Tischler L Weissbach U R?th A Haupt P Sch?ffski A Harstrick HJ Schmoll 《Canadian Metallurgical Quarterly》1996,7(10):1015-1021
BACKGROUND: Cisplatin-based combination chemotherapy will cure 70% to 80% of patients with metastatic non-seminomatous germ cell tumors but is associated with the possibility of severe neuro-, oto- and nephro-toxicities. Carboplatin, a cisplatin analogue, is an active drug in testicular cancer with a more favourable spectrum of side effects. In a randomized trial, the German Testicular Cancer Study Group compared a combination regimen of carboplatin, etoposide and bleomycin (CEB) to standard cisplatin, etoposide and bleomycin (PEB) chemotherapy for patients with 'minimal-' and moderate-disease' non-seminomatous germ cell tumors, according to the Indiana University classification. PATIENTS AND METHODS: PEB was given for three cycles at standard doses (given days 1-5), and the CEB regimen consisted of carboplatin (target AUC of 5 mg/ml x min) on day 1, etoposide 120 mg/m2 on days 1 to 3 and bleomycin 30 mg on days 1, 8 and 15. Four cycles of CEB were given, with the omission of bleomycin in the fourth cycle. Thus, the cumulative doses of etoposide and bleomycin applied in the two treatment arms were comparable. Fifty-four patients were entered on the trial, 29 were treated with PEB and 25 with CEB chemotherapy. Patients were stratified according to disease extent (minimal versus moderate) and the degree of tumor marker elevation. Thirty-two patients (59%) belonged to the group with minimal disease and low markers. RESULTS: No significant difference in response to chemotherapy was seen between the two arms, with CR rates of 81% for the PEB arm and 76% for CEB treatment. However, more patients treated with CEB (32% versus 13%) have relapsed after therapy, and 4 patients (16%) have died of disease progression after CEP in contrast to 1 (3%) after PEB therapy. The first interim analysis of negative events (relapse, vital tumor at secondary resection, death from disease and therapy-associated death) showed a significantly higher rate after CEB than after PEB therapy, and the trial was terminated early. After a median follow-up of 33 months for all patients, the calculation of negative events is still significantly in favour of PEB-treated patient, particularly since three late relapses > 2 years have been observed in the CEB arm (P = 0.03). CONCLUSION: This randomized trial demonstrates that even with the use of adequate doses of etoposide and full-dose bleomycin, carboplatin cannot altogether replace cisplatin in patients with testicular cancer. Treatment with the PEB regimen remains the standard approach in patients with 'good-risk' non-seminomatous germ cell tumors. 相似文献
8.
A two-dimensional finite element model was constructed to analyze the simulated mechanical behavior of a cantilevered fixed partial denture. The variations of the models were made by altering the degree of bone support, the number of splinted abutments, and the length of the pontics. High stress concentrations were observed around the connectors of the fixed prosthesis and the tooth closest to the cantilever. Reduced bone support increased the deflection and stress concentrations. There was reduction in displacement and stress concentration when the teeth were splinted together. To improve the prognosis of the fixed partial denture cantilever, the number of abutments should be increased and the number of pontics decreased. 相似文献
9.
Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects 总被引:1,自引:0,他引:1
TP Links AJ Smit WM Molenaar MJ Zwarts HJ Oosterhuis 《Canadian Metallurgical Quarterly》1994,122(1):33-43
A model of induced lactation was modified to examine the effects of bovine prolactin (bPRL) and bovine placental lactogen (bPL) on mammary growth and differentiation. Thirty-two peripubertal, non-pregnant Holstein heifers were given daily s.c. injections of oestradiol (0.05 mg/kg) and progesterone (0.25 mg/kg) for 7 days to initiate mammary growth. Treatment with bromocriptine (40 mg/3 days) reduced serum PRL concentrations to approximately 25% of pretreatment levels, for the duration of the study. On the day following the last steroid injection, groups of eight heifers were given twice daily s.c. injections of either saline (negative control), recombinant bPRL (rbPRL; 80 mg/day) or recombinant bPL (rbPL; 80 and 160 mg/day) for 7 days. At the end of this period (day 15), growth and differentiation of the mammary glands were assessed. Treatment with rbPL increased total mammary DNA above control value by 50 and 60% for the 80 and 160 mg/day doses respectively. However, total DNA was not different for the control and rbPRL-treated groups. The blood serum concentration of alpha-lactalbumin was measured daily throughout the study and used as an index of mammary differentiation. Both rbPRL and rbPL stimulated mammary differentiation (i.e. induction of milk synthesis), although rbPRL appeared to be more potent than rbPL. These results indicate that rbPL is lactogenic in vivo and strongly suggest that bPL is a mammary mitogen. 相似文献
10.